Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Eskişehir
Clinical trial register · Turkey

Clinical Trials in Eskişehir, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5443 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5443
Studies in scope
all four open statuses
2494
Recruiting now
open to new participants
547
Lead sponsors
across recruiting studies
Top sites
Ankara 7 Antalya 6 Mersin 5 Istanbul 5 Kocaeli 5
Narrow the registerReset
Recruitment status
Phase
Site location
Ankara7 Antalya6 Mersin5 Istanbul5 Kocaeli5
All 18 locations
Target enrolment
to

Trials with a site in Eskişehir

3 of 5443 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Eli Lilly and Company
Phase 2
252
Adana, Ankara, Antalya, Eskişehir, Hatay, İzmit, Malatya, Mersin
2025-11-10
Recruiting
Eli Lilly and Company
Phase 3
350
Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit
2025-06-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Istanbul- Fatih, Ankara, Antalya, Edirne, Eskişehir, Istanbul, Kocaeli
2023-10-25
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-turkey/city/eski-ehir

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,443 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Eskişehir that also match the filters currently applied.

How many clinical trials are recruiting in Eskişehir?

2 of the 3 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Eskişehir), 3 studies
PhaseStudiesRecruitingShare
Phase 32166.7%
Phase 21133.3%

Most active sponsors

Lead sponsors with the most studies (Eskişehir)
Lead sponsorStudiesRecruiting
Eli Lilly and Company22
Merck Sharp & Dohme LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.